In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.32 million shares changing hands with its beta currently measuring 1.43. Company’s recent per share price level of $1.50 trading at -$0.02 or -1.32% at ring of the bell on the day assigns it a market valuation of $437.57M. That closing price of PROK’s stock is at a discount of -196.0% from its 52-week high price of $4.44 and is indicating a premium of 10.67% from its 52-week low price of $1.34.

For ProKidney Corp (PROK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.

ProKidney Corp (NASDAQ:PROK) trade information

Upright in the red during last session for losing -1.32%, in the last five days PROK remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $1.50 price level, adding 10.18% to its value on the day. ProKidney Corp’s shares saw a change of -11.24% in year-to-date performance and have moved -6.25% in past 5-day. ProKidney Corp (NASDAQ:PROK) showed a performance of -10.18% in past 30-days.

Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a rise of 62.5% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -100.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -100.0% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around -2.23% while estimates for its earnings growth in next 5 years are of -4.91%.

On the other hand, Vanguard Total Stock Market Index Fund and Morgan Stanley Inst Fd Inc-Growth Port are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.97 shares of worth $4.45 million or 2.32% of the total outstanding shares. The later fund manager was in possession of 2.92 shares on Sep 30, 2024 , making its stake of worth around $4.39 million in the company or a holder of 2.28% of company’s stock.